MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by CareDx, Inc.

< Previous 1 2 3 4 5 Next >
News headline image
CareDx Announces Dismissal of 2021 Qui Tam Suit
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces First Quarter 2026 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation’s 46th Annual Meeting
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces Fourth Quarter and Full Year 2025 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
From CareDx, Inc.
Via Business Wire
Tickers CDNA TXG
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Provides Notice of Proposed Derivative Settlement
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx to Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces Third Quarter 2025 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors
From CareDx, Inc.
Via Business Wire
Tickers CDNA
News headline image
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025
From CareDx, Inc.
Via Business Wire
Tickers CDNA
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story